The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Clinical and genomic predictors of response and toxicity to sotorasib in a real-world cohort of patients with advanced KRAS G12C-mutant non-small cell lung cancer.
 
Kathryn C. Arbour
Consulting or Advisory Role - Genzyme; Novartis; Sanofi
Research Funding - Genentech (Inst); Mirati Therapeutics (Inst); Revolution Medicines (Inst)
 
Rohit Thummalapalli
No Relationships to Disclose
 
Ezra Bernstein
No Relationships to Disclose
 
Benjamin Herzberg
Honoraria - Eisai
Consulting or Advisory Role - Amgen
Research Funding - Amgen (Inst); Astellas Pharma (Inst); IDEAYA Biosciences (Inst); Repare Therapeutics (Inst); Revolution Medicines (Inst)
 
Bob T. Li
Research Funding - Ambrx (Inst); Amgen (Inst); AstraZeneca (Inst); Bolt Biotherapeutics (Inst); Daiichi Sankyo (Inst); Hengrui Therapeutics (Inst); Lilly (Inst); MORE Health (Inst); Roche/Genentech (Inst)
Patents, Royalties, Other Intellectual Property - Karger Publishers - Book royalty; Shanghai Jiao Tong University Press - Book royalty; US62/514,661 (Inst); US62/685,057 (Inst)
Travel, Accommodations, Expenses - Jiangsu Hengrui Medicine; MORE Health
(OPTIONAL) Uncompensated Relationships - Amgen; AstraZeneca; Boehringer Ingelheim; Daiichi Sankyo; Genentech; Lilly
 
Afsheen Iqbal
No Relationships to Disclose
 
Fernando Costa Santini
Honoraria - Amgen; Bayer
Consulting or Advisory Role - Bayer; Lilly
Speakers' Bureau - Bayer
 
Juliana Eng
No Relationships to Disclose
 
Marc Ladanyi
Consulting or Advisory Role - ADC Therapeutics; AstraZeneca; Bayer; Merck; Paige.AI
Research Funding - Elevation Oncology (Inst); Merus NV (Inst); Rain Therapeutics
 
Soo-Ryum Yang
Honoraria - Prime Education
Consulting or Advisory Role - InVitae
 
Ronglai Shen
No Relationships to Disclose
 
Piro Lito
Leadership - Frontier Medicines
Stock and Other Ownership Interests - Frontier Medicines
Consulting or Advisory Role - AmMax Bio; Black Diamond Therapeutics; Frontier Medicines; OrbiMed; Repare Therapeutics; Revolution Medicines
Speakers' Bureau - Boehringer Ingelheim
Research Funding - Amgen (Inst); Boehringer Ingelheim (Inst); Mirati Therapeutics (Inst); Revolution Medicines (Inst); Virtec pharmaceuticals (Inst)
Patents, Royalties, Other Intellectual Property - I am listed as an inventor on a patent application filed by MSKCC that describes an approach to treat BRAF mutant cancers. (Inst); I am listed as an inventor on a patent application filed by MSKCC that describes an approach to treat KRAS mutant cancers. (Inst)
 
Joshua K. Sabari
Consulting or Advisory Role - AstraZeneca; Janssen Oncology; Medscape; Navire; Pfizer; Regeneron; Takeda
 
Gregory J. Riely
Research Funding - Lilly (Inst); Merck (Inst); Mirati Therapeutics (Inst); Novartis (Inst); Pfizer (Inst); Rain Therapeutics (Inst); Rain Therapeutics (Inst); Roche/Genentech (Inst); Takeda (Inst)
Patents, Royalties, Other Intellectual Property - Patent application submitted covering pulsatile use of erlotinib to treat or prevent brain metastases (Inst)
Travel, Accommodations, Expenses - Bayer; Merck
Other Relationship - Mirati Therapeutics; Pfizer; Roche/Genentech; Takeda